Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to respond to targeted therapies. To better understand which patients may respond ...

TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors under a spotlight.

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.